Ipsen

This study follows 30 people with Alagille syndrome who are already taking odevixibat, a drug that helps with liver-related itching. Researchers will watch for side effects over time to see how safe the drug is in everyday use. The goal is to gather real-world safety information,…

This study monitors pregnant individuals who took elafibranor shortly before or during pregnancy. It aims to understand risks to the mother and baby, including birth defects. The study is observational, meaning no extra treatments or tests are given—only routine medical data is c…